| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2541281 | International Immunopharmacology | 2010 | 7 Pages |
The present study was conducted to investigate the effects of Baicalein (BE), which is hydrolyzed product of Baicalin (BA), on atopic dermatitis (AD). AD was induced in NC/Nga mice by DPE treatment. BE hydrogels treatment reduced the levels of skin severity scores. BE hydrogels treatment also decreased inflammatory cytokines such as TNF-α, IL-6, and its level in the serum. BE hydrogels treatment elevated IFN-γ level in the spleenocyte culture supernatant. Cell numbers in the skin positive to CD3+/CD69+, CCR3+, CD11b+/Gr-1+, B220+/IgE+ all of which were up-regulated in AD-induced mice were decreased and returned to normal levels. Histological examination showed that infiltration levels of immune cells in the skin of AD-induced NC/Nga mice were much improved by BE hydrogels treatment. These results thus suggest that BE can regulate molecular mediators and immune cells that are functionally associated with atopic dermatitis induced in NC/Nga mice, and may play an important role in recovering AD symptoms.
Graphical AbstractThe inhibitory effects of BE hydrogel on the expression of cytokines in atopic dermatitis imply that it could be developed as a novel anti-atopic therapy.Figure optionsDownload full-size imageDownload as PowerPoint slideResearch Highlights► The values of clinical skin by BE hydrogel treatment decreased at 8 and 16 weeks. ► The immune cell isolated from NC/Nga mice skin by BE hydrogel treatment decreased significantly. ► BE hydrogel treatment decreased inflammatory cytokines such as TNF-α, IL-6, levels in the serum. ► BE can regulate molecular mediators and immune cells and recovers atopic dermatitis symptoms.
